Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1996 2
1999 1
2000 1
2001 1
2002 4
2003 3
2005 4
2006 2
2007 2
2008 4
2009 7
2010 7
2011 13
2012 5
2013 7
2014 3
2015 6
2016 6
2017 8
2018 7
2019 7
2020 5
2021 14
2022 11
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma.
Clavería-Cabello A, Herranz JM, Latasa MU, Arechederra M, Uriarte I, Pineda-Lucena A, Prosper F, Berraondo P, Alonso C, Sangro B, García Marin JJ, Martinez-Chantar ML, Ciordia S, Corrales FJ, Francalanci P, Alaggio R, Zucman-Rossi J, Indersie E, Cairo S, Domingo-Sàbat M, Zanatto L, Sancho-Bru P, Armengol C, Berasain C, Fernandez-Barrena MG, Avila MA. Clavería-Cabello A, et al. Among authors: pineda lucena a. J Hepatol. 2023 Oct;79(4):989-1005. doi: 10.1016/j.jhep.2023.05.031. Epub 2023 Jun 10. J Hepatol. 2023. PMID: 37302584 Free article.
Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression.
Arroyo-Crespo JJ, Armiñán A, Charbonnier D, Deladriere C, Palomino-Schätzlein M, Lamas-Domingo R, Forteza J, Pineda-Lucena A, Vicent MJ. Arroyo-Crespo JJ, et al. Among authors: pineda lucena a. Int J Cancer. 2019 Oct 15;145(8):2267-2281. doi: 10.1002/ijc.32270. Epub 2019 Apr 2. Int J Cancer. 2019. PMID: 30860605 Free PMC article.
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.
Macaya I, Roman M, Welch C, Entrialgo-Cadierno R, Salmon M, Santos A, Feliu I, Kovalski J, Lopez I, Rodriguez-Remirez M, Palomino-Echeverria S, Lonfgren SM, Ferrero M, Calabuig S, Ludwig IA, Lara-Astiaso D, Jantus-Lewintre E, Guruceaga E, Narayanan S, Ponz-Sarvise M, Pineda-Lucena A, Lecanda F, Ruggero D, Khatri P, Santamaria E, Fernandez-Irigoyen J, Ferrer I, Paz-Ares L, Drosten M, Barbacid M, Gil-Bazo I, Vicent S. Macaya I, et al. Among authors: pineda lucena a. Nat Commun. 2023 Oct 10;14(1):6332. doi: 10.1038/s41467-023-41828-z. Nat Commun. 2023. PMID: 37816716 Free PMC article.
Metabolomics in pharmaceutical research and development.
Puchades-Carrasco L, Pineda-Lucena A. Puchades-Carrasco L, et al. Among authors: pineda lucena a. Curr Opin Biotechnol. 2015 Dec;35:73-7. doi: 10.1016/j.copbio.2015.04.004. Epub 2015 Apr 17. Curr Opin Biotechnol. 2015. PMID: 25900094 Review.
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gómez-Cebrián N, Poveda JL, Pineda-Lucena A, Puchades-Carrasco L. Gómez-Cebrián N, et al. Among authors: pineda lucena a. Cancers (Basel). 2022 Jan 25;14(3):596. doi: 10.3390/cancers14030596. Cancers (Basel). 2022. PMID: 35158864 Free PMC article. Review.
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N, Vázquez Ferreiro P, Carrera Hueso FJ, Poveda Andrés JL, Puchades-Carrasco L, Pineda-Lucena A. Gómez-Cebrián N, et al. Among authors: pineda lucena a. Pharmaceuticals (Basel). 2021 Oct 2;14(10):1015. doi: 10.3390/ph14101015. Pharmaceuticals (Basel). 2021. PMID: 34681239 Free PMC article. Review.
AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity.
Botella-Asunción P, Rivero-Buceta EM, Vidaurre-Agut C, Lama R, Rey-Campos M, Moreno A, Mendoza L, Mingo-Casas P, Escribano-Romero E, Gutierrez-Adan A, Saiz JC, Smerdou C, Gonzalez G, Prosper F, Argemí J, Miguel JS, Sanchez-Cordón PJ, Figueras A, Quesada-Gomez JM, Novoa B, Montoya M, Martín-Acebes MA, Pineda-Lucena A, Benlloch JM. Botella-Asunción P, et al. Among authors: pineda lucena a. Biomed Pharmacother. 2023 Dec 31;169:115882. doi: 10.1016/j.biopha.2023.115882. Epub 2023 Nov 18. Biomed Pharmacother. 2023. PMID: 37984300 Free article.
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.
Ruiz-Fernández de Córdoba B, Moreno H, Valencia K, Perurena N, Ruedas P, Walle T, Pezonaga-Torres A, Hinojosa J, Guruceaga E, Pineda-Lucena A, Abengózar-Muela M, Cochonneau D, Zandueta C, Martínez-Canarias S, Teijeira Á, Ajona D, Ortiz-Espinosa S, Morales X, Ortiz de Solórzano C, Santisteban M, Ramos-García LI, Guembe L, Strnad V, Heymann D, Hervás-Stubbs S, Pío R, Rodríguez-Ruiz ME, de Andrea CE, Vicent S, Melero I, Lecanda F, Martínez-Monge R. Ruiz-Fernández de Córdoba B, et al. Among authors: pineda lucena a. Cancer Discov. 2022 May 2;12(5):1356-1377. doi: 10.1158/2159-8290.CD-21-0932. Cancer Discov. 2022. PMID: 35191482 Free PMC article.
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer.
Nunes SP, Morales L, Rubio C, Munera-Maravilla E, Lodewijk I, Suárez-Cabrera C, Martínez VG, Pérez-Escavy M, Pérez-Crespo M, Alonso Sánchez M, Montesinos E, San José-Enériz E, Agirre X, Prósper F, Pineda-Lucena A, Henrique R, Dueñas M, Correia MP, Jerónimo C, Paramio JM. Nunes SP, et al. Among authors: pineda lucena a. Cell Death Discov. 2024 Jan 4;10(1):1. doi: 10.1038/s41420-023-01786-3. Cell Death Discov. 2024. PMID: 38172127 Free PMC article.
134 results